Compare Novo Nordisk A/S (NVO) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Valero Energy Corporation — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while Valero Energy Corporation trades at $313.92 (market cap $93.03B). The key difference: Novo Nordisk A/S is far larger — about 2.4× Valero Energy Corporation's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| NVO | VLO | |
|---|---|---|
Market Cap | $220.53B | $93.03B |
Sector | Health | Energy |
52-Week High | $71.70 | $313.31 |
52-Week Low | $35.29 | $131.77 |
Enterprise Value | $239.49B | $98.79B |
Dividend Yield | 3.63% | 1.53% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
